At #AACR26, Emily Schahrer presents data showing that immune checkpoint inhibitor treatment can cause colitis, a major immune-related adverse event, potentially working through reactivation of CD8+ tissue resident memory T cells. @UChicagoPME @UChicagoCCB @UChicagoCOI https://t.co/ZecMyiQRfU